Showing 221 - 240 results of 254 for search '"University of Oslo"', query time: 0.07s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228

    Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data St... by Puco K, Notland CS, Szulkin R, Jonasson C, Beisland C, Johannesen TB, Solli O, Oldenburg J, Heinrich D

    Published 2025-01-01
    “…Katarina Puco,1 Cathrine S Notland,2 Robert Szulkin,3,4 Christian Jonasson,5 Christian Beisland,6,7 Tom B Johannesen,8 Oddvar Solli,9 Jan Oldenburg,10,11 Daniel Heinrich12 1Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway; 2Department of Medical Affairs, Pfizer AS, Oslo, Norway; 3SDS Life Science, Stockholm, Sweden; 4Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden; 5Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 6Department of Urology, Haukeland University Hospital, Bergen, Norway; 7Department of Clinical Medicine, University of Bergen, Bergen, Norway; 8Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; 9Health and Value, Pfizer AS, Oslo, Norway; 10Department of Oncology, Akershus University Hospital HF, Lørenskog, Norway; 11Faculty of Medicine, University of Oslo, Oslo, Norway; 12Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, NorwayCorrespondence: Katarina Puco, Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway, Tel +47  416 86 298, Email katarina.puco@lds.noPurpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. …”
    Get full text
    Article
  9. 229
  10. 230
  11. 231
  12. 232
  13. 233

    Extensive Inactive Neurocysticercosis: A Case Report in Mbeya, Southern Highlands of Tanzania by Makasi CE, Ngowi BJ, Stelzle D, Kilale AM, Mahande MJ, Welte TM, Winkler AS, Mmbaga BT

    Published 2025-01-01
    “…Charles Elias Makasi,1,2 Bernard James Ngowi,3 Dominik Stelzle,4 Andrew Martin Kilale,1 Michael Johnson Mahande,2,5 Tamara Margarete Welte,4 Andrea Sylvia Winkler,4,6 Blandina Theophil Mmbaga2,7 1National Institute for Medical Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania; 2Kilimanjaro Christian Medical University College of Tumaini University, Moshi, Tanzania; 3University of Dar Es Salaam, Mbeya College of Health and Allied Sciences, Mbeya, Tanzania; 4Department of Neurology and Center for Global Health, School of Medicine and Health, Technical University Munich, Munich, Germany; 5Department of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania; 6Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway; 7Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, TanzaniaCorrespondence: Charles Elias Makasi, Email charlesemakasi@gmail.comBackground: Neurocysticercosis (NCC) and Acquired Human Immunodeficiency Syndrome (AIDS) are both highly prevalent in Africa. …”
    Get full text
    Article
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239
  20. 240